OVID logo

Ovid Therapeutics (OVID) Net Income

Annual Net Income

-$52.34 M
+$1.83 M+3.38%

December 31, 2023

Summary

Performance

1-Year Change

+3.38%

3-Year Change

+35.41%

5-Year Change

-0.69%

15-Year Change

+19.24%

OVID Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.47%
OVID annual net profit is higher than 36.47% of companies in Healthcare sector

High & Low

All-time High

$122.83 M
OVID annual net profit is currently -142.61% below its historical high of $122.83 million

3-Year Low

-$54.17 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OVID previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
OVID next annual earnings announcement is scheduled for Mar 7, 2025

OtherOVIDprofitabilitymetrics:

Annual Net Margin

-13.36 K%
OVID annual net profit margin is -13.36 thousand%

Annual Revenue

$391.70 K
OVID annual revenue is $391.70 thousand

Annual Gross Profit

-
OVID annual gross profit value is unknown

Annual EPS

-$0.74
OVID annual earnings per share is -$0.74

Quarterly Net Income

-$14.01 M
-$22.53 M-264.37%

September 30, 2024

Summary

Performance

3-Month Change

-264.37%

1-Year Change

+8.59%

3-Year Change

+8.59%

5-Year Change

+8.59%

OVID Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.72%
OVID quarterly net profit is higher than 33.72% of companies in Healthcare sector

High & Low

All-time High

$176.01 M
OVID quarterly net profit is currently -107.96% below its historical high of $176.01 million

3-Year Low

-$26.00 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OVID previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
OVID next earnings announcement is scheduled for Mar 7, 2025

OtherOVIDprofitabilitymetrics:

Quarterly Net Margin

-8095.95%
OVID quarterly net profit margin is -8095.95%

Quarterly Revenue

$173.00 K
OVID quarterly revenue is $173.00 thousand

Quarterly Gross Profit

-
OVID quarterly gross profit value is unknown

Quarterly EPS

-$0.20
OVID quarterly earnings per share is -$0.20

TTM Net Income

-$32.50 M
-$2.75 M-9.25%

September 30, 2024

Summary

Performance

3-Month Change

-9.25%

1-Year Change

+37.9%

3-Year Change

+37.9%

5-Year Change

+37.9%

OVID TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.56%
OVID TTM net profit is higher than 46.56% of companies in Healthcare sector

High & Low

All-time High

$126.81 M
OVID TTM net profit is currently -125.63% below its historical high of $126.81 million

3-Year Low

-$69.28 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OVID previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
OVID next earnings announcement is scheduled for Mar 7, 2025

OtherOVIDprofitabilitymetrics:

Annual Net Margin

-13.36 K%
OVID annual net profit margin is -13.36 thousand%

TTM Revenue

$631.70 K
OVID TTM revenue is $631.70 thousand

TTM Gross Profit

-
OVID TTM gross profit value is unknown

TTM EPS

-$0.47
OVID TTM earnings per share is -$0.47

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$52.34 M
OVID annual net profit is -$52.34 million

Annual Revenue

$391.70 K
OVID annual revenue is $391.70 thousand

Annual Cost Of Goods Sold

-
OVID annual cost of goods sold value is unknown

Annual Operating Expenses

$59.67 M
OVID annual total operating expenses is $59.67 million

Annual Interest Expense

-
OVID annual interest expense value is unknown

Annual Income Tax

$0.00
OVID annual income tax is $0.00

OVID Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.4%+8.6%+37.9%
3 y3 years+35.4%+8.6%+37.9%
5 y5 years-0.7%+8.6%+37.9%

OVID Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-142.6%+3.4%-264.4%+46.1%-126.5%+53.1%
5 y5-year-142.6%+35.4%-108.0%+46.1%-125.6%+59.9%
alltimeall time-142.6%+35.4%-108.0%+59.1%-125.6%+59.9%

Ovid Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$14.01 M(-264.4%)
-$32.50 M(+9.3%)
Jun 2024
-
$8.52 M(-172.9%)
-$29.75 M(-41.3%)
Mar 2024
-
-$11.69 M(-23.7%)
-$50.68 M(-3.2%)
Dec 2023
-$52.34 M(-3.4%)
-$15.32 M(+36.2%)
-$52.34 M(+7.9%)
Sep 2023
-
-$11.25 M(-9.3%)
-$48.52 M(-1.5%)
Jun 2023
-
-$12.41 M(-7.1%)
-$49.24 M(-4.2%)
Mar 2023
-
-$13.36 M(+16.1%)
-$51.42 M(-5.1%)
Dec 2022
-$54.17 M(-144.1%)
-$11.50 M(-3.9%)
-$54.17 M(-21.1%)
Sep 2022
-
-$11.97 M(-18.0%)
-$68.66 M(+0.9%)
Jun 2022
-
-$14.59 M(-9.4%)
-$68.08 M(-1.7%)
Mar 2022
-
-$16.11 M(-38.0%)
-$69.28 M(-156.4%)
Dec 2021
$122.83 M(-251.6%)
-$26.00 M(+128.4%)
$122.83 M(-3.1%)
Sep 2021
-
-$11.38 M(-27.9%)
$126.81 M(+4.1%)
Jun 2021
-
-$15.79 M(-109.0%)
$121.76 M(+5.9%)
Mar 2021
-
$176.01 M(-899.0%)
$115.00 M(-241.9%)
Dec 2020
-$81.04 M
-$22.03 M(+34.1%)
-$81.04 M(+6.7%)
Sep 2020
-
-$16.42 M(-27.2%)
-$75.98 M(-0.3%)
Jun 2020
-
-$22.55 M(+12.6%)
-$76.19 M(+14.2%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$20.03 M(+18.0%)
-$66.69 M(+10.3%)
Dec 2019
-$60.46 M(+16.3%)
-$16.97 M(+2.0%)
-$60.46 M(+7.2%)
Sep 2019
-
-$16.63 M(+27.4%)
-$56.39 M(+7.0%)
Jun 2019
-
-$13.06 M(-5.4%)
-$52.72 M(+0.2%)
Mar 2019
-
-$13.80 M(+7.0%)
-$52.60 M(+1.2%)
Dec 2018
-$51.98 M(-19.8%)
-$12.90 M(-0.5%)
-$51.98 M(+3.9%)
Sep 2018
-
-$12.96 M(+0.2%)
-$50.04 M(+7.8%)
Jun 2018
-
-$12.94 M(-1.9%)
-$46.44 M(+6.1%)
Mar 2018
-
-$13.18 M(+20.3%)
-$43.75 M(-32.5%)
Dec 2017
-$64.81 M(+189.1%)
-$10.96 M(+17.1%)
-$64.81 M(+5.5%)
Sep 2017
-
-$9.36 M(-8.7%)
-$61.41 M(+6.2%)
Jun 2017
-
-$10.25 M(-70.1%)
-$57.83 M(+9.2%)
Mar 2017
-
-$34.24 M(+352.8%)
-$52.97 M(+136.3%)
Dec 2016
-$22.41 M(+70.3%)
-$7.56 M(+30.7%)
-$22.41 M(+50.9%)
Sep 2016
-
-$5.79 M(+7.4%)
-$14.85 M(+63.8%)
Jun 2016
-
-$5.39 M(+46.3%)
-$9.07 M(+146.3%)
Mar 2016
-
-$3.68 M
-$3.68 M
Dec 2015
-$13.16 M
-
-

FAQ

  • What is Ovid Therapeutics annual net profit?
  • What is the all time high annual net income for Ovid Therapeutics?
  • What is Ovid Therapeutics annual net income year-on-year change?
  • What is Ovid Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Ovid Therapeutics?
  • What is Ovid Therapeutics quarterly net income year-on-year change?
  • What is Ovid Therapeutics TTM net profit?
  • What is the all time high TTM net income for Ovid Therapeutics?
  • What is Ovid Therapeutics TTM net income year-on-year change?

What is Ovid Therapeutics annual net profit?

The current annual net income of OVID is -$52.34 M

What is the all time high annual net income for Ovid Therapeutics?

Ovid Therapeutics all-time high annual net profit is $122.83 M

What is Ovid Therapeutics annual net income year-on-year change?

Over the past year, OVID annual net profit has changed by +$1.83 M (+3.38%)

What is Ovid Therapeutics quarterly net profit?

The current quarterly net income of OVID is -$14.01 M

What is the all time high quarterly net income for Ovid Therapeutics?

Ovid Therapeutics all-time high quarterly net profit is $176.01 M

What is Ovid Therapeutics quarterly net income year-on-year change?

Over the past year, OVID quarterly net profit has changed by +$1.32 M (+8.59%)

What is Ovid Therapeutics TTM net profit?

The current TTM net income of OVID is -$32.50 M

What is the all time high TTM net income for Ovid Therapeutics?

Ovid Therapeutics all-time high TTM net profit is $126.81 M

What is Ovid Therapeutics TTM net income year-on-year change?

Over the past year, OVID TTM net profit has changed by +$19.84 M (+37.90%)